ArticleScientific reports2025
Fabrication and characterizations of 3D printed GelMA-Gel/bioactive glass scaffolds containing cerium for bone damage repair.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antimicrobial Gelatin Methacryloyl (GelMA)/Bioactive Glass Dental Adhesives.Journal of functional biomaterials · 2026Article
- Physical and Mechanical Characterisation of 3D-Bioprinted Hydrogels for Dental Applications: A Scoping Review.Gels (Basel, Switzerland) · 2026Review
- Ethanol precipitation with cooling enables rapid purification of gelatin methacryloyl (GelMA) with increased yield and preserved solution-state organisation.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Gelatin methacryloyl (GelMA) and bioactive glasses (BGs) have attracted considerable scientific interest as scaffold materialsin bone tissue engineering, particularly for their structural applications in bone repair procedures. Cerium (Ce) can be incorporated into BGs, demonstrating beneficial effects on osteogenesis and regenerative processes. In this study, we fabricated GelMA-Gel scaffolds using a 3D printing method and evaluated the impact of BG and BG/Ce inclusion through in vitro and in vivo assessments. Scanning electron microscopy images revealed an interconnected porous structure within the scaffolds. The incorporation of Ce appeared to enhance the mechanical properties of the scaffolds. Additionally, the inclusion of Ce did not induce cytotoxicity and positively influenced the viability and proliferation of human bone marrow-derived mesenchymal stem cells while enhancing alkaline phosphatase secretion compared to other samples. No edema or erythema response was observed in the Guinea Pig Maximization Test (GPMT) following the implantation of GelMA-Gel-BG/Ce scaffolds. Implantation of the scaffolds into cranial bone defects in rats over 12 weeks demonstrated enhanced bone formation and mineralization, as evidenced by histological staining. The results indicate that the GelMA-Gel-BG/Ce scaffold is biocompatible and capable of promoting bone regeneration, highlighting its potential as an effective implant for addressing bone injuries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.